QEI
CLB icon

QSV Equity Investors’s Core Laboratories CLB Stock Holding History

QSV Equity Investors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-88,455
Closed -$1.33M – 91
2025
Q1 		$1.33M Buy
88,455
+29,197
+49% +$489K 1.37% 34
2024
Q4 		$1.03M Buy
59,258
+73
+0.1% +$1.41K 0.99% 54
2024
Q3 		$1.1M Sell
59,185
-20,205
-25% -$406K 1.03% 57
2024
Q2 		$1.61M Sell
79,390
-2,708
-3% -$47.9K 1.68% 23
2024
Q1 		$1.4M Buy
82,098
+59
+0.1% +$928 1.35% 42
2023
Q4 		$1.45M Buy
+82,039
New +$1.65M 1.41% 36

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

QSV Equity Investors's CLB Position: Q2 2025 in Review

QSV Equity Investors sold out of Core Laboratories (CLB) in Q2 2025, closing a stake of 88,455 shares — an estimated $1.33M sold.

QSV Equity Investors first reported a position in CLB in Q4 2023 and held it in 6 quarters. The position peaked at $1.61M in Q2 2024. 191 funds tracked by Wall St. Rank hold CLB as of Q2 2025.

  • QSV Equity Investors reported no remaining Core Laboratories position as of Q2 2025 after selling out during the quarter.
  • QSV Equity Investors sold 88,455 Core Laboratories shares in Q2 2025, an estimated $1.33M.
  • QSV Equity Investors first reported a position in Core Laboratories in Q4 2023 and held it in 6 quarters.
  • QSV Equity Investors's Core Laboratories position peaked at $1.61M in Q2 2024.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2025.

Based on QSV Equity Investors's 13F filing for Q2 2025, filed 13 Aug 2025.